Thomas T, Rauscher F, Sanders R, Veltman J, Watkins J B
Medical Sciences Program, Indiana University School of Medicine, Bloomington 47405-7005, USA.
Toxicol Sci. 2000 Jan;53(1):145-9. doi: 10.1093/toxsci/53.1.145.
Aldose reductase has been implicated in the etiology of diabetic complications, atherosclerosis, and ischemia-reperfusion injury. Aldose reductase inhibitors are known to have species-dependent differences in biotransformation enzyme induction. Whether aldose reductase inhibitors, which have antioxidant potential, alter the oxidative stress pathway is unknown. This study has determined whether four daily ip treatments of either low (10 mg/kg) or high (50 mg/kg) doses of AL-1576 or AL-4114 alter the activities of the antioxidant defense enzymes catalase, glutathione reductase, glutathione peroxidase, superoxide dismutase, and the concentrations of reduced and oxidized glutathione in livers of normal rats and rabbits. There was no change in the concentration of thiobarbituric acid reactive substances in either rat or rabbit livers, indicating that lipid peroxidation was not increased by any treatment. Hepatic catalase, superoxide dismutase, and glutathione peroxidase activities and concentrations of reduced and oxidized glutathione were not significantly altered in rat, though glutathione reductase activity was increased after high doses of both drugs. However, in rabbit liver, glutathione reductase activity decreased in a dose-dependent manner after AL-4114 treatment, while superoxide dismutase and glutathione peroxidase activities decreased only after the low dose of AL-4114. Although AL-4114 and AL-1576 did not directly generate increased lipid peroxidation within normal rat and rabbit livers, some of the enzymes responsible for oxidative defense were altered, particularly in rabbit livers.
醛糖还原酶与糖尿病并发症、动脉粥样硬化及缺血再灌注损伤的病因有关。已知醛糖还原酶抑制剂在生物转化酶诱导方面存在物种依赖性差异。具有抗氧化潜力的醛糖还原酶抑制剂是否会改变氧化应激途径尚不清楚。本研究确定了每日腹腔注射四次低剂量(10毫克/千克)或高剂量(50毫克/千克)的AL - 1576或AL - 4114是否会改变正常大鼠和兔子肝脏中抗氧化防御酶过氧化氢酶、谷胱甘肽还原酶、谷胱甘肽过氧化物酶、超氧化物歧化酶的活性以及还原型和氧化型谷胱甘肽的浓度。大鼠或兔子肝脏中硫代巴比妥酸反应性物质的浓度均未发生变化,表明任何处理均未增加脂质过氧化。大鼠肝脏中的过氧化氢酶、超氧化物歧化酶和谷胱甘肽过氧化物酶活性以及还原型和氧化型谷胱甘肽的浓度均未显著改变,不过高剂量的两种药物处理后谷胱甘肽还原酶活性增加。然而,在兔子肝脏中,AL - 4114处理后谷胱甘肽还原酶活性呈剂量依赖性降低,而超氧化物歧化酶和谷胱甘肽过氧化物酶活性仅在低剂量的AL - 4114处理后降低。虽然AL - 4114和AL - 1576在正常大鼠和兔子肝脏中未直接导致脂质过氧化增加,但一些负责氧化防御的酶发生了改变,尤其是在兔子肝脏中。